“Celiac Disease Market” has been added to DelveInsight
Celiac Disease Overview
Chronic kidney disease (CKD) is a syndrome where there are persistent alterations in kidney structure, function, or both with implications on the health of the individual. Examples of structural abnormalities include cysts, tumors, malformations and atrophy, which are evident on imaging. By contrast, kidney dysfunction can manifest as hypertension, edema, and changes in output or quality of urine and growth delay in children. These changes are most often recognized by increased serum levels of creatinine, cystatin C, or blood urea nitrogen. Moreover, the most common pathological manifestation of CKD, regardless of the initiating insult or disease, is some form of renal fibrosis.
Celiac Disease Market Insights
DelveInsight’s ‘Celiac Disease Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get a free Celiac Disease report sample page- https://www.delveinsight.com/sample-request/celiac-disease-cd-market
Celiac Disease Market: Regions Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Celiac Disease Market Report
- Research Analysis
- Market Analysis
- Pipeline Valuation
- Market Size by therapies
- Market Share by therapies
Celiac Disease Treatment
Chronic kidney disease (CKD) is a type of kidney disease in which there is a gradual loss of kidney function over a period of months to years. The initial symptoms include leg swelling, feeling tired, vomiting, loss of appetite, and confusion; complications in CKD involve anemia, bone disease, high blood pressure and increased risk of heart disease. Anemia is common and is especially prevalent in those requiring hemodialysis. The mechanism of anemia in CKD are multifactorial and include increased inflammation, reduction in erythropoietin, and hyperuricemia leading to bone marrow suppression. There are different types of medications available in the market. Available medicines cannot reverse CKD; however, they are used to treat complications and to slow further kidney damage.
Celiac Disease Market: Key Players
- GlaxoSmithKline
- Akebia Therapeutics
- AstraZeneca
- Chong Kun Dang Pharmaceuticals
Celiac Disease Market: Drugs
- Latiglutenase
- Larazotide
Celiac Disease Market Size
The increase in market size is a direct consequence of increasing prevalent population of Chronic Kidney Disease (CKD) patients in the 7MM, along with the expected entry of premium price asset such Anti-inflammatories, Prolyl hydroxylase and IL-6 inhibitors, which will have a significant impact on the market size. The market size of Chronic Kidney Disease (CKD) is anticipated to increase during the study period, 2017–2030.
Celiac Disease Market Insights
Chronic kidney disease (CKD) is a type of kidney disease in which there is a gradual loss of kidney function over a period of months to years. The initial symptoms include leg swelling, feeling tired, vomiting, loss of appetite, and confusion; complications in CKD involve anemia, bone disease, high blood pressure and increased risk of heart disease. Anemia is common and is especially prevalent in those requiring hemodialysis. The mechanism of anemia in CKD are multifactorial and include increased inflammation, reduction in erythropoietin, and hyperuricemia leading to bone marrow suppression.
Table of content
1 Key Insights
2 Celiac Disease Market Overview at a Glance
3 Executive Summary of Celiac Disease (CD)
4 Disease Background and Overview: Celiac Disease
5 Algorithm for Diagnosis of CD
6 Diagnostic Guidelines by the European Society for the Study of Coeliac Disease (ESsCD)
7 Diagnostic Guidelines by the World Gastroenterology Organization (WGO)
8 Epidemiology and Patient Population: Key Findings
9 Country Wise-Epidemiology of Celiac Disease
10 Treatment
11 Treatment Algorithm for CD
12 Treatment Algorithm for CD by BMJ Best Practice
13 European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders
14 World Gastroenterology Organisation Global Guidelines for CD
15 Recognized Establishments
16 Unmet Needs
17 Emerging Drugs
18 Celiac Disease: 7 Major Market Analysis
19 The United States Market Outlook
20 EU-5 Countries: Market Outlook
21 Japan Market Outlook
22 KOL Reviews
23 Case Reports
24 Market Drivers
25 Market Barriers
26 SWOT Analysis
27 Appendix
28 DelveInsight Capabilities
29 Disclaimer
30 About DelveInsight
Why should you buy this report?
- The report will help in creating business methodologies by understanding patterns forming and driving the Celiac Disease market
- To comprehend the future market rivalry in the Celiac Disease market and Insightful survey of the key market drivers and hindrances
- Sort out deals and promoting endeavors by recognizing the best open doors for Celiac Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- ID of solid impending parts in the market will help in formulating procedures that will help in advancing beyond contenders
- Coordinate deals and showcasing endeavors by recognizing the best open doors for Celiac Disease market
- To comprehend the future market rivalry in the Celiac Disease market
You can check our related reports-
About Us
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
